Loss of RIZ1, a methyltransferase targeting lysine nine on histone H3, has been frequently observed in lung, breast, hepatocellular, colon, neuroblastoma, and melanoma, suggesting its potential role as a tumor suppressor in these malignancies [43]. The gene discussed is PRDM2; the disease is neuroblastoma.